Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT


Primary Symbol: V.RHT.H Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by BigDan44on Jun 29, 2018 12:15pm
160 Views
Post# 28251874

RE:RE:Share-based payments

RE:RE:Share-based paymentsLol that's actually incorrect.

A quick trip to SEDI will show you that none of the granted options have been exercised by Lisa or Amandeep have yet to convert their shares yet the expense was still booked in the annual FS. 

https://www.canadianinsider.com/node/7?menu_tickersearch=Reliq+Health+Technologies+Inc.+%7C+RHT

The expense recorded is indeed a non-cash item and is priced as per the black scholes model. Basically, the model approximates the cost to the company for the in the money share options granted to management. It's a non cash item because no actual cash is paid to the employee, rather this piece of paper is granted. 

In terms of alignment, it does mean management has an incentive to maximize their SP so when they convert options, they do so for the most amount of profit possible. 

The key thing that is wrong is that ESOs (employee stock options) are not valued on conversion, they're valued when granted (with parameters including current SP, exercise price, duration of option, etc. -> look up the model for more detail). If RHT stock price was at a cent, the expense would still be recorded on the books when granted. When Lisa exercises her options, there will be no impact on the company other than an increase in cash for the amount exercised (ie. 1.12 * shares exercies) and an increase in share capital for the same amount. The share count would also increase but that is not a strict accounting journal entry.


DoubleDownPmt wrote:

Executives are granted stock options - the ability to buy shares at a pre-determined price, at some point in the future - as part of their compensation/wage.

This way, the more the shares are worth, the more the executives can earn. Owners and Executives then have the same goal - to increase share price.

Usually the options to buy shares are granted at a pre-determined price, close to the current trading price. Not long ago the shares were less than 20 cents.

In the future (now) when executives exercise their rights to convert their options to buy shares (paying the company the pre-determined price per share)...if the shares are trading higher than the option conversion price, the company has to report the value difference in trading price to option conversion price as a loss.

This is because they "sold" a small amount of ownership of the company for less than they could have otherwise.

This is a very good thing for everybody, investors included.

So, in other words, RHT has performed so well that the executive's (and investors') earnings are very high, and the executives' earnings are, just like regular employee wages, a cost of running a business.

If RHT was still trading at 20 cents there would be no loss, and RHT would have a much smaller "loss" on paper. Again,as an investor, I want the execs to get paid when I get paid, and I much rather have shares worth $1.88,  than shares worth 20 cent shares but lower share-based compensation.

You can imagine the payments as a commission or bonus for doing a good job.



Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse